Arega Pharma
ActiveSummary
The computed 12-month bankruptcy probability of Arega Pharma is 2.7% (moderate). The 2025 annual accounts show equity of €9.8m and a net result of €6.4m. Equity is growing by about 55% per year across the filed financial years. Its solvency ranks better than 20% of 6,105 sector peers (NACE 46, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Connections & network
8 current directorsThe board mandates are listed below; here you explore them as a network.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.